Kariya Pharmaceuticals has taken a unique approach with KP405, a first-in-class dual GLP-1/GIP receptor agonist with the potential to synergistically reduce neuroinflammation, enhance mitochondrial function and support neuronal survival
Back Blume, N, Skouv, J, Larson, L-I, et al (Nov 1995) 'Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis', Journal of Clinical Investigations , 96, 2227-35
Novo says it's the only drugmaker to manufacture an FDA-approved Wegovy pill formulated with SNAC technology, which facilitates semaglutide absorption when administered orally
Semaglutide helped bring GLP-1 weight loss therapy into mainstream awareness
Zhu A, Andino J, Daignault-Newton S, Chopra Z, Sarma A, Dupree JM
Thats substantially more than whats typically achieved with behavioral interventions alone